Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.
Radiation therapy aims to kill cancer cells with a minimum of normal tissue toxicity. Dying cancer cells have been proposed to be a source of tumor antigens and may release endogenous immune adjuvants into the tumor environment. For these reasons, radiation therapy may be an effective modality to in...
Guardado en:
Autores principales: | Marka R Crittenden, Benjamin Cottam, Talicia Savage, Cynthia Nguyen, Pippa Newell, Michael J Gough |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97e5e31feaef4c54a3fffb274b2ef53f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
por: Marka R. Crittenden, et al.
Publicado: (2018) -
The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis
por: Hui Li, et al.
Publicado: (2017) -
GPI-80 Augments NF-κB Activation in Tumor Cells
por: Yuji Takeda, et al.
Publicado: (2021) -
Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression
por: Paulina Nastały, et al.
Publicado: (2021) -
Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
por: Sara A Byron, et al.
Publicado: (2012)